Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis
Authors:
- 27 September 2021
- journal article
- case report
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 28 (2) , 486-488
Abstract
Introduction: Acute pancreatitis associated with Pazopanib has been reported in the literature. Bitter Melon (Momordica Charantia) is traditionally used as a folk medicine in many regions. In this report, we describe a 65-year-old patient with a diagnosis of renal cell carcinoma, admitted to the hospital with symptoms of acute pancreatitis at the 8th year of pazopanib treatment. Case Report: The patient diagnosed with renal cell carcinoma was admitted to the hospital with the complaint of abdominal pain, nausea, and vomiting in the 8th year of Pazopanib treatment. It was noticed from the patient's history that he had received Bitter Melon extract for 4 days prior to the beginning of his complaints (100–150 ml/day). Levels of serum amylase and lipase were measured as 9163 U/L and 14,206 U/L, respectively. Management & Outcome: Pazopanib drug was held. The patient was treated for acute pancreatitis. Pazopanib treatment was started again after the clinical condition of the patient had improved and levels of serum amylase and lipase had returned to normal levels. Levels of serum amylase and lipase did not increase again after re-administration of pazopanib treatment. Discussion: It is thought that Bitter Melon extract and pazopanib interaction might have led to acute pancreatitis. To the best of our knowledge, this case is the first to highlight the interaction of Bitter Melon extract with pazopanib. The Drug Interaction Probability Scale indicates that there is a probable association between bitter melon and acute pancreatitis.Keywords
This publication has 14 references indexed in Scilit:
- Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activationToxicology, 2016
- Use of traditional medicine in middle-income countries: a WHO-SAGE studyHealth Policy and Planning, 2016
- Pazopanib and pancreatic toxicity: a case reportBMC Research Notes, 2015
- Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitorsCritical Reviews in Oncology/Hematology, 2015
- Enzyme-Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase InhibitorsJournal of Pharmaceutical Sciences, 2014
- Drug interactions with solid tumour-targeted therapiesCritical Reviews in Oncology/Hematology, 2014
- Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cellsCarcinogenesis, 2013
- Proposal for a New Tool to Evaluate Drug Interaction CasesAnnals of Pharmacotherapy, 2007
- Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extractCancer Chemotherapy and Pharmacology, 2004
- Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesisToxicology Letters, 1998